Value-Based Agreements – Are We Going to See More or Less of Them?
Sydney Otomancek2022-01-05T11:26:30-05:00Value, Evidence, Access|
Mike Pace, MBA, Pierre Etienne, MD, and Clifton Chow give an insightful and practical webinar on one of the most important areas in pharmaceutical value and market access.